The non-nucleoside reverse transcriptase inhibitor efavirenz (Sustiva, also in the Atripla single-tablet regimen) was not associated with a higher rate of suicidal thoughts or attempts in an analysis conducted by manufacturer Bristol-Myers Squibb (BMS), researchers reported at the 2014 IDWeek meeting last week in Philadelphia.
16 October 2014 | HIVandHepatitis.com
A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends. The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.
02 July 2014 | Web MD
Zimbabwean people living with HIV recently took part in a 12-week course on dealing with self-stigma and other negative thoughts that people have in relation to themselves. The initiative was different in the sense that previous efforts to address HIV-related stigma have focused on “changing people out there,” the project manager, Nadine Ferris France told us. “We don’t have many programmes that are actually focused on us, programmes that are dealing with the negative thoughts that we have about ourselves and that’s self-stigma,” she said.
17 April 2014 | Key Correspondents
Pregnant and early postnatal migrant women are a heterogeneous and far more diverse population group than has previously been experienced. Migrant women experiencing maternal mental health related illnesses face practical barriers and cultural factors which may prevent them from seeking help.
14 March 2014 | Better Health
This issue addresses some of the complex and evolving mental health needs of older adults living with HIV.
21 February 2014 | American Psychological Association
Researchers in the European Union and Australia conducted research into perceived barriers to starting ART. A primary barrier for HIV-positive people is not feeling sufficiently unwell or having symptoms. Doctors delayed initiation of ART when they perceived patients to be suffering from depression, if there was substance use or if they believed that patients did not understand the need to adhere to HIV medicines.
19 February 2014 | CATIE
In the first study to look at the consequences of anti-gay prejudice for mortality, researchers at Columbia University's Mailman School of Public Health found that lesbian, gay, and bisexual (LGB) individuals who lived in communities with high levels of anti-gay prejudice have a shorter life expectancy of 12 years on average compared with their peers in the least prejudiced communities. "The results of this study suggest a broadening of the consequences of prejudice to include premature death," noted the study's lead author, Mark Hatzenbuehler, PhD, assistant professor of Sociomedical Sciences. The study is online in the journal Social Science & Medicine.
16 February 2014 | Mailman School of Public Health
What's it like to be newly diagnosed today? Guest writer Scotspozlad found out he was HIV-positive in October 2013. Here he tells what happened and how he felt about it.
04 November 2013 | Positive Lite
British charity The Samaritans have revealed how thousands of calls to the listening service are from men confused, depressed or even suicidal over their sexuality.
25 October 2013 | Gay Star News
Last week I tweeted, "Thinking about loneliness as a driver for HIV infection among black gay men." I think that the issue of loneliness is perhaps critical to how we think about HIV prevention and treatment issues.
17 October 2013 | Huffington Post